Cancer Clinical Trial - Pyxis 201

Status:

Recruiting

ClinicalTrials.gov:

NCT05720117

 

A First-in-Human, Open-label, Multicenter, Phase 1 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of PYX-201 in Participants With Advanced Solid Tumors.

Drug

PYX-201

Age Range

18 Years and older

Phase

Phase 1